Arbutus (ABUS) delivered earnings and revenue surprises of -9.52% and 12.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...
Are These On Your List Of Penny Stocks To Buy Right Now?
One of the things we’ve discussed when it comes to penny stocks is price. Obviously, we’re talking...